It has nothing to do with impatience but taking ad
Post# of 30028
Posted On: 10/22/2014 11:16:28 PM
It has nothing to do with impatience but taking advantage of an opportunity to let others know about a breakthrough diagnostic. Gerald mentioned before about broadcasting the release of Lympro. I believe Dave can back me up on that. But then again, if Lympro is only targeting RUO, we might not see much of a pr blitz.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.
Scroll down for more posts ▼